olsalazine, Dipentum (cont.)

Pharmacy Author:
Medical and Pharmacy Editor:

PREGNANCY: It is not known whether olsalazine crosses the placenta to the fetus.

NURSING MOTHERS: Mesalamine, which is the active form of olsalazine, may be secreted into breast milk and cause diarrhea in the infant.

SIDE EFFECTS: Gastrointestinal disturbances commonly occur in persons who take olsalazine. Diarrhea occurs in about 1 of every 6 persons who take it; about one in 20 need to discontinue therapy because the diarrhea is severe. Abdominal pain or cramps occur in 1 in 10 persons, and nausea or vomiting occurs in 1 in 20. Other side effects, including dizziness, depression, and headache, occur less frequently than gastrointestinal effects during therapy. Rashes occur in 2.3% of persons and joint pain in 4%.

Reference: FDA Prescribing Information


Medically Reviewed by a Doctor on 11/29/2012


Report Problems to the Food and Drug Administration

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Pill Finder Tool

Need help identifying pills and medications?
Use the pill identifier tool on RxList.


Back to Medications Index